Select Medical (NYSE:SEM) Upgraded to “Hold” at Zacks Research

Zacks Research upgraded shares of Select Medical (NYSE:SEM) from a strong sell rating to a hold rating in a report released on Monday morning,Zacks.com reports.

A number of other research analysts have also recently commented on SEM. Wall Street Zen cut Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 9th. Weiss Ratings upgraded Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, February 20th. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $16.50 price objective (down from $19.00) on shares of Select Medical in a research report on Tuesday, March 3rd. Finally, Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, March 4th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $15.63.

Select Medical Trading Up 0.0%

Shares of SEM opened at $16.45 on Monday. The company’s fifty day simple moving average is $16.16 and its 200-day simple moving average is $15.26. The company has a market cap of $2.04 billion, a P/E ratio of 15.51, a P/E/G ratio of 0.94 and a beta of 1.02. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.88. Select Medical has a twelve month low of $11.65 and a twelve month high of $16.99.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.07). Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The firm had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the previous year, the company posted $0.44 earnings per share. The business’s revenue for the quarter was up 5.0% on a year-over-year basis. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, analysts expect that Select Medical will post 1.27 EPS for the current year.

Select Medical declared that its board has initiated a share buyback plan on Thursday, February 19th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the health services provider to purchase up to 49.5% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board believes its shares are undervalued.

Select Medical Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 28th. Stockholders of record on Thursday, May 14th will be given a $0.0625 dividend. This represents a $0.25 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend is Thursday, May 14th. Select Medical’s dividend payout ratio is presently 23.58%.

Institutional Trading of Select Medical

Hedge funds have recently bought and sold shares of the stock. Smartleaf Asset Management LLC boosted its position in Select Medical by 37.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider’s stock valued at $43,000 after acquiring an additional 788 shares in the last quarter. State of Alaska Department of Revenue lifted its stake in shares of Select Medical by 1.5% during the 4th quarter. State of Alaska Department of Revenue now owns 63,370 shares of the health services provider’s stock worth $940,000 after purchasing an additional 935 shares during the last quarter. Wilmington Savings Fund Society FSB boosted its position in Select Medical by 20.9% during the third quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock valued at $74,000 after purchasing an additional 999 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH grew its stake in Select Medical by 9.7% in the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 11,475 shares of the health services provider’s stock valued at $171,000 after purchasing an additional 1,014 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund grew its stake in Select Medical by 5.1% in the third quarter. Oregon Public Employees Retirement Fund now owns 24,816 shares of the health services provider’s stock valued at $319,000 after purchasing an additional 1,200 shares during the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.